Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Patient Satisfaction 1Neutropenia 1Leiomyoma 1Central Line-associated Bloodstream Infection (CLABSI) 1Benign Female Reproductive System Neoplasm 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Vascular Access Devices × Clear all
NCT02728999 2024-10-04

Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?

Wake Forest University Health Sciences

Phase NA Terminated
22 enrolled

Benign Female Reproductive System Neoplasm

NCT05740150 2023-02-22

CATERPILLAR

Princess Maxima Center for Pediatric Oncology

Phase NA Unknown
462 enrolled

Central Line-associated Bloodstream Infection (CLABSI)

NCT03021720 2021-02-25

SPARQLE

Mount Sinai Hospital, Canada

Phase NA Completed
40 enrolled

Leiomyoma, Patient Satisfaction

NCT04103021 2019-09-25

Ultrasound Guided Port-A-Cath Isertion in Cancer Patients

Assiut University

Phase NA Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Universitair Ziekenhuis Brussel

Phase 4 Unknown
15 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡